Approval summary: gemtuzumab ozogamicin in relapsed acute myeloid leukemia.Peter Bross, Richard Pazdur, Julie Beitz et al.|PubMed|2001Cited by 861
United States Food and Drug Administration Drug Approval SummaryMartin H. Cohen, Richard Pazdur, Atiqur Rahman et al.|Clinical Cancer Research|2004Cited by 500
Approval summary for imatinib mesylate capsules in the treatment of chronic myelogenous leukemia.Martin H. Cohen, Richard Pazdur, Grant Williams et al.|PubMed|2002Cited by 469
Approval Summary: Azacitidine for Treatment of Myelodysplastic Syndrome SubtypesEdvardas Kaminskas, Richard Pazdur, Ann Farrell et al.|Clinical Cancer Research|2005Cited by 424
Predicting lake water quality index with sensitivity-uncertainty analysis using deep learning algorithmsSwapan Talukdar, G. V. Ramana, Shahfahad et al.|Journal of Cleaner Production|2023Cited by 122